FDA Generics Office Drinks Super Serum, Then Shrinks
OGD sheds almost half its staff as part of an organizational elevation.
You may also be interested in...
The group will be called the Office of Therapeutic Products, but needs more people to handle its increasing workload.
The move should increase the visibility of the FDA’s wide-ranging, and widely criticized, opioid epidemic response.
Kathleen Uhl gave seven months' notice of her retirement, which may allow new director to be hired and on-boarded before she departs.